The Environmental Protection Agency's Office of Research and Development has been eliminated, marking a victory for industry coalitions seeking to limit chemical risk assessments. Over 80 industry groups urged this change, citing concerns over the effectiveness and transparency of the EPA's Integrated Risk Information System program. Industry representatives claimed that the ORD’s practices jeopardized access to critical chemical technologies and harmed national competitiveness. Experts assert that the future of vital research into chemical risks is now uncertain, raising alarms about public health implications.
EPA's IRIS program within ORD has a troubling history of being out of step with the best available science and methods, lacking transparency, and being unresponsive to peer review and stakeholder recommendations. This results in IRIS assessments that jeopardize access to critical chemistries, undercut national priorities, and harm American competitiveness.
The future of that research, conducted under EPA's Integrated Risk Information System program, or IRIS, is now uncertain following the dismantling of the agency's Office of Research and Development.
Collection
[
|
...
]